Vistagen announces preliminary positive data in ongoing open-label extension portion of PALISADE-3 phase 3 study of fasedienol for the acute treatment of social anxiety disorder

Published: 2026-05-12 08:58:13 ET VTGN

Published on 05/12/2026 at 08:58 am EDT